Mr. Schellin is an entrepreneurially minded C-level executive and business strategist diagnosing and building alignment around market opportunities and taking organizations from challenges to thriving enterprises. Mr. Schellin excels at creating a vision of the future, bringing people together around the mission and inspiring engagement and action to achieve goals. He has over 25 years of experience in the Life Sciences industry, ranging from startup to international multi-site responsibility across the small and large molecule drug product, drug substance, and medical device sectors. Mr. Schellin has held senior executive level positions with operating leadership roles, focusing on M&A evaluations, pre- and post-integration strategy, execution of integration plans, along with buy side and sell side advisory. He successfully developed a specialty sterile and drug delivery CDMO business in Irvine, California, subsequently selling it to Siegfried. Prior to entering the consulting field, Mr. Schellin was Siegfried's SVP, Global Head of Drug Product Operations and US Drug Substance. Today, Mr. Schellin provides consulting services to the Life Science industry though his boutique consulting firm, where he specializes in operational performance, interim management, site evaluations, mergers, acquisitions, and post integration support. He focuses on assisting companies with strategic decisions, and business operations advisory. Mr. Schellin holds a bachelor's degree in Political Science and Business Administration from DePaul University.